Loading company…
Zewei Biological researches drug targets and develops technologies for cancer drug discovery.
Zewei Biological provides target discovery and validation, biological mechanism research and preclinical research. Its TRiC platform is designed to capture tumor targets. Founded in 2022, the company is based in Nanjing, China. It raised CNY 10 million in angel funding in April 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in